Abstract:Vitamin D deficiency is considered a pandemic and has been postulated to increase the risk of type 2 diabetes mellitus (T2DM). Activation of nod-like receptor protein 3 (NLRP3) signaling induced by hyperglycemia stress has been recognized as a key priming stage for pancreatic β-cell inflammation in T2DM pathogenesis. AMP-activated protein kinase (AMPK) activation attenuates NLRP3 inflammasome upregulation in diabetes. This study investigated whether vitamin D3 could protect cells against high glucose-induced inflammation by modulating this critical step. A human cross-sectional study of 78 healthy, glucose-tolerant volunteers and 399 patients with type 2 diabetes was undertaken. The relationship between serum 25(OH)D3 levels and β-cell function was assessed using Pearson correlation analysis and multiple linear regression, and a high-glucose diet-induced rat model of impaired glucose tolerance was used to evaluate the effects of cholecalciferol. Intraperitoneal glucose tolerance tests and an ELISA were performed to detect the function of pancreatic islets. Glucose-stimulated insulin secretion, pyroptosis, reactive oxygen species (ROS) production, and NLRP3 pathway were evaluated together to determine the role of vitamin D in high glucose-induced pancreatic β-cell dysfunction in INS-1E cells. The clinical results showed a positive association between serum 25(OH)D3 levels and β-cell function in male patients with type 2 diabetes. In vivo, cholecalciferol significantly reduced blood glucose levels and improved insulin secretion in response to glucose loading in the high glucose diet-induced rat model. In vitro studies have demonstrated that 1,25(OH)<sub>2</sub>D3 promotes insulin release in both islets and INS-1E cells. Mechanistically, our results demonstrated that vitamin D3 can activate AMPK, inhibiting the mTOR pathway, thus inhibiting NLRP3 inflammasome activation and alleviating pyroptosis in β-cell dysfunction. This study showed that vitamin D protects against high-glucose-induced β-cell dysfunction by enhancing the AMPK pathway, thereby suppressing NLRP3 inflammasome activation.

Kindlin-2 Protects Pancreatic Β Cells Through Inhibiting NLRP3 Inflammasome Activation in Diabetic Mice.

Vitamin D protects against high glucose-induced pancreatic β-cell dysfunction via AMPK-NLRP3 inflammasome pathway

Vitamin D protects against high glucose-induced pancreatic 13-cell dysfunction via AMPK-NLRP3 inflammasome pathway

Inhibition of Ca2+-Independent Phospholipase A2β (ipla2β) Ameliorates Islet Infiltration and Incidence of Diabetes in NOD Mice

Pancreatic kallikrein protects against diabetic retinopathy in KK Cg-Ay/J and high-fat diet/streptozotocin-induced mouse models of type 2 diabetes

Pyruvate Kinase, Muscle Isoform 2 Promotes Proliferation And Insulin Secretion Of Pancreatic Beta-Cells Via Activating Wnt/Ctnnb1 Signaling

Kindlin-2 enhances c-Myc translation through association with DDX3X to promote pancreatic ductal adenocarcinoma progression

NK3-Like NK Cells Are Involved in Protective Effect of Polyinosinic-Polycytidylic Acid on Type 1 Diabetes in Nonobese Diabetic Mice

B Lymphocytes Expressing High Levels of PD-L1 Are Key Regulators of Diabetes Development in Non-Obese Diabetic Mice.

KCa3.1 Channel Mediates Inflammatory Signaling of Pancreatic Β Cells and Progression of Type 2 Diabetes Mellitus

LINC-p21 Regulates Pancreatic β-Cell Function in Type 2 Diabetes Mellitus

cNPAS2 induced β cell dysfunction by regulating KANK1 expression in type 2 diabetes

Insulin Reduces Inflammation by Regulating the Activation of the NLRP3 Inflammasome

Inhibition of the Keap1/Nrf2 Signaling Pathway Significantly Promotes the Progression of Type 1 Diabetes Mellitus

Kindlin-2 haploinsufficiency protects against fatty liver by targeting Foxo1 in mice

Correction: Kindlin-2 Maintains Liver Homeostasis by Regulating GSTP1-OPN-mediated Oxidative Stress and Inflammation in Mice.

IL-33 promotes pancreatic β-cell survival and insulin secretion under diabetogenic conditions through PPARγ

Attenuates Inflammation in Diabetes-Induced Kidney Injury by Targeting NLRP3 Inflammasome

Kindlin-2 controls angiogenesis through modulating Notch1 signaling

MiR-17-5p Inhibits TXNIP/NLRP3 Inflammasome Pathway and Suppresses Pancreatic β-Cell Pyroptosis in Diabetic Mice

Perilipin5 protects against lipotoxicity and alleviates endoplasmic reticulum stress in pancreatic β-cells